In breast cancer, PXDN overexpression is associated with advanced tumor grade, lymph node metastasis, and distant dissemination; patients with high PXDN expression exhibit reduced disease-free and overall survival [21]. The gene discussed is PXDN; the disease is breast carcinoma.